Advertisement

Beyond cut-off values for hypertension… individualize interventions

Published:January 15, 2018DOI:https://doi.org/10.1016/j.ejim.2018.01.018
      The recently proposed new classification and intervention for hypertension published by the ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Panel [
      • Whelton P.K.
      • Carey R.M.
      • Aronow W.S.
      • Casey D.E.
      • Collins K.J.
      • Dennison Himmelfarb C.
      • et al.
      ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary.
      ] have caused lots of controversy since it lowers the cut-off value from 140/90 to 130/80 mm Hg to initiate a pharmacological intervention. This guideline focuses on the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults, however, the main controversy lies on recommending a pharmacological intervention to patients reaching 140/90 mm Hg and people with 130/80 mm Hg and cardiovascular risk higher than 10%. This decision was supported in multiple studies describing an increased risk of coronary, stroke events, renal and other end-point organs damage, as the pressure rises.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Whelton P.K.
        • Carey R.M.
        • Aronow W.S.
        • Casey D.E.
        • Collins K.J.
        • Dennison Himmelfarb C.
        • et al.
        ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary.
        Hypertension. 2017; 2017 (doi:10.1161/HYP.0000000000000066): e00
        • The SPRINT Research Group
        A randomized trial of intensive versus standard blood-pressure control.
        N Engl J Med. 2015; 373: 2103-2116https://doi.org/10.1056/NEJMoa1511939
        • Lonn E.M.
        • Bosch J.
        • López-Jaramillo P.
        • Zhu J.
        • Liu L.
        • Pais P.
        • et al.
        Blood-pressure lowering in intermediate-risk persons without cardiovascular disease.
        N Engl J Med. 2016; 374: 2009-2020https://doi.org/10.1056/NEJMoa1600175
        • Brunström M.
        • Carlberg B.
        Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels.
        JAMA Intern Med. 2018; 178: 28-36https://doi.org/10.1001/jamainternmed.2017.6015
        • Wise I.A.
        • Charchar F.J.
        Epigenetic modifications in essential hypertension.
        Int J Mol Sci. 2016; 17: 451https://doi.org/10.3390/ijms17040451